| Date Filed | Type | Description |
| 08/08/2023 |
4
| Bryant Diane M (Director) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 2,226 shares
@ $0 |
|
| 08/08/2023 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 2,226 shares
@ $0 |
|
| 08/08/2023 |
4
| Zane Ellen M (Director) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 2,226 shares
@ $0 |
|
| 08/08/2023 |
4
| Pomeroy Claire (Director) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 2,226 shares
@ $0 |
|
| 08/08/2023 |
4
| KROLL MARK W (Director) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 2,226 shares
@ $0 |
|
| 08/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2023 |
4
| COYLE MICHAEL J (Director) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 2,226 shares
@ $0 |
|
| 08/08/2023 |
4
| ABERNATHY ROBERT E (Director) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 2,226 shares
@ $0 |
|
| 08/08/2023 |
3
| Bryant Diane M (Director) has filed a Form 3 on HAEMONETICS CORP |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2023 |
4
| Simon, Christopher (President & CEO) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 117,667 shares
@ $84.84, valued at
$10M
Exercised 196,746 options to buy
@ $28.615, valued at
$5.6M
|
|
| 06/09/2023 |
4
| Strong Stewart W (President, Global Hospital) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 5,053 shares
@ $88, valued at
$444.7k
Sold 2,538 shares
@ $88.04, valued at
$223.4k
Exercised 4,483 options to buy
@ $56.57, valued at
$253.6k
Exercised 2,410 options to buy
@ $57.6, valued at
$138.8k
|
|
| 06/01/2023 |
4
| Lingamneni Anila (EVP, Chief Technology Officer) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Sold 2,304 shares
@ $83.33, valued at
$192k
|
|
| 05/19/2023 |
4
| Basil Michelle L (EVP and General Counsel) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 3,541 shares
@ $83.34, valued at
$295.1k
|
|
| 05/19/2023 |
4
| Lingamneni Anila (EVP, Chief Technology Officer) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 1,385 shares
@ $83.34, valued at
$115.4k
|
|
| 05/19/2023 |
4
| Llorens Josep (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 1,423 shares
@ $83.34, valued at
$118.6k
|
|
| 05/19/2023 |
4
| Miller Laurie A. (SVP, Human Resources) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 90 shares
@ $83.34, valued at
$7.5k
|
|
| 05/19/2023 |
4
| Simon, Christopher (President & CEO) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 3,839 shares
@ $83.34, valued at
$319.9k
|
|
| 05/19/2023 |
4
| Strong Stewart W (President, Global Hospital) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 1,087 shares
@ $83.34, valued at
$90.6k
|
|
| 05/17/2023 |
4
| Maunsell Farris Maryanne (VP, Chief Accounting Officer) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 630 shares
@ $0
Granted 1,425 options to buy
@ $89.16, valued at
$127.1k
|
|
| 05/17/2023 |
4
| Strong Stewart W (President, Global Hospital) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 2,803 shares
@ $0
Paid exercise price by delivering 250 shares
@ $89.21, valued at
$22.3k
Granted 6,335 options to buy
@ $89.16, valued at
$564.8k
|
|
| 05/17/2023 |
4
| Miller Laurie A. (SVP, Human Resources) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 2,102 shares
@ $0
Paid exercise price by delivering 235 shares
@ $89.21, valued at
$21k
Granted 4,751 options to buy
@ $89.16, valued at
$423.6k
|
|
| 05/17/2023 |
4
| Lingamneni Anila (EVP, Chief Technology Officer) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 3,364 shares
@ $0
Paid exercise price by delivering 318 shares
@ $89.21, valued at
$28.4k
Granted 7,602 options to buy
@ $89.16, valued at
$677.8k
|
|
| 05/17/2023 |
4
| Llorens Josep (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 3,084 shares
@ $0
Paid exercise price by delivering 319 shares
@ $89.21, valued at
$28.5k
Granted 6,968 options to buy
@ $89.16, valued at
$621.3k
|
|
| 05/17/2023 |
4
| Galvin Roy (President, Global Plasma & BC) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 2,243 shares
@ $0
Granted 5,068 options to buy
@ $89.16, valued at
$451.9k
|
|
| 05/17/2023 |
4
| Basil Michelle L (EVP and General Counsel) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 4,205 shares
@ $0
Paid exercise price by delivering 446 shares
@ $89.21, valued at
$39.8k
Granted 9,502 options to buy
@ $89.16, valued at
$847.2k
|
|
| 05/17/2023 |
4
| DArecca James (EVP, CFO) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 4,205 shares
@ $0
Paid exercise price by delivering 349 shares
@ $89.21, valued at
$31.1k
Granted 9,502 options to buy
@ $89.16, valued at
$847.2k
|
|
| 05/17/2023 |
4
| Simon, Christopher (President & CEO) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 18,225 shares
@ $0
Paid exercise price by delivering 1,586 shares
@ $89.21, valued at
$141.5k
Granted 41,177 options to buy
@ $89.16, valued at
$3.7M
|
|
| 05/16/2023 |
4
| Basil Michelle L (EVP and General Counsel) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 204 shares
@ $88.16, valued at
$18k
|
|
| 05/16/2023 |
4
| Llorens Josep (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 113 shares
@ $88.16, valued at
$10k
|
|
| 05/16/2023 |
4
| Simon, Christopher (President & CEO) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 854 shares
@ $88.16, valued at
$75.3k
|
|
| 05/16/2023 |
4
| Miller Laurie A. (SVP, Human Resources) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Paid exercise price by delivering 32 shares
@ $88.16, valued at
$2.8k
|
|
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|